Search results
SpringWorks (SWTX) Rises More Than 40% in a Year: Here's Why
Zacks via Yahoo Finance Canada· 19 hours agoSpringWorks' (SWTX) Ogsiveo is the first drug approved by the FDA to treat desmoid tumors. The...
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
Zacks via Yahoo Finance Canada· 19 hours agoVerona Pharma (VRNA) surges on the recent FDA approval for its lead drug, which is the first inhaled...
Inovio (INO) Up as Lead Drug Gets Innovative Medicine Tag in UK
Zacks via Yahoo Finance Canada· 20 hours agoInovio (INO) soars 19% as its lead candidate, INO-3107, receivesthe innovative medicine tag under ...
Microbot Medical (MBOT) Progresses in Its Human Clinical Trial
Zacks via Yahoo Finance Canada· 2 days agoMicrobot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected...
Select Medical (SEM) Expands Rehabilitation Services in Central PA
Zacks via Yahoo Finance Canada· 2 days agoSelect Medical (SEM) and UPMC unveil a 20-bed satellite facility of Helen M. Simpson Rehabilitation...
That slickest move by Edmonton Oilers GM Jeff Jackson that you just can't get out of your head
Edmonton Journal· 2 days agoIf you’re a fan of the Edmonton Oilers, you likely have a slick move made by Edmonton Oilers...
NetApp (NTAP) Unveils Advanced Capabilities for Cloud Platforms
Zacks via Yahoo Finance Canada· 2 days agoNetApp, Inc. NTAP recently added innovative capabilities to its intelligent data portfolio, tailored...
First Solar (FSLR) Rises 33% Year to Date: Should You Buy Now?
Zacks via Yahoo Finance Canada· 2 days agoFirst Solar (FSLR) rides on enhancing manufacturing capacities and innovating new products, backed...
Dropbox (DBX) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance Canada· 3 days agoThe stock's change was less than the S&P 500's daily gain of 1.02%. Meanwhile, the Dow gained 1.09%,...
Zevra (ZVRA) Rises on Update on Niemann-Pick Disease Type C Drug
Zacks via Yahoo Finance Canada· 3 days agoThe FDA will meet with its Genetic Metabolic Diseases Advisory Committee to review Zevra's (ZVRA)...